Agex Therapeutics Inc Stock Ownership - Who owns Agex Therapeutics?

Insider buying vs selling

Have Agex Therapeutics Inc insiders been buying or selling?
Michael D. WestChief Executive Officer2023-03-111,060$0.59
Michael D. WestChief Executive Officer2022-12-111,081$0.59

1 of 1

AGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AGE insiders and whales buy or sell their stock.

AGE Shareholders

What type of owners hold Agex Therapeutics Inc stock?
Juvenescence Us Corp43.34%16,447,500$12.37MInsider
Juvenescence Ltd43.34%16,447,500$12.37MInsider
Broadwood Capital Inc7.90%2,997,156$2.25MInstitution
Vanguard Group Inc1.84%698,414$525.21kInstitution
Prescott General Partners LLC0.49%185,185$139.26kInstitution
Bridgeway Capital Management LLC0.38%144,770$108.87kInstitution
Sigma Planning Corp0.37%139,700$105.05kInstitution
Blackrock Inc0.35%131,844$99.15kInstitution
John F. Mauldin0.33%125,000$94.00kInsider
Geode Capital Management LLC0.26%97,764$73.52kInstitution

1 of 3

AGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGE12.50%87.35%Net Selling
ELDN23.38%76.62%Net Buying
SABS7.56%76.89%Net Buying
ABIO1.95%98.05%Net Buying

Agex Therapeutics Stock Ownership FAQ

Who owns Agex Therapeutics?

Agex Therapeutics (NYSEMKT: AGE) is owned by 12.50% institutional shareholders, 87.35% Agex Therapeutics insiders, and 0.15% retail investors. Juvenescence Us Corp is the largest individual Agex Therapeutics shareholder, owning 16.45M shares representing 43.34% of the company. Juvenescence Us Corp's Agex Therapeutics shares are currently valued at $12.37M.

If you're new to stock investing, here's how to buy Agex Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.